Page 46 - Jurnal Farmasi Klinik Vol 4 No 1

Jurnal Farmasi Klinik Best Practice Volume 4 No 1

13. Chrousos GP. https://doi.org/10.1186/1758-

Adrenocorticosteroids and 5996-5-18.

adrenocortical antagonist. Dalam: 17. van Raalte DH, Nofrate V,
Katzung BG, Masters SB, Bunck MC, et al. Acute and 2-

Trevor AJ. Basic and clinical week exposure to prednisolone
pharmacology. Edisi ke-12. New impair different aspects of beta-

York: Mc-Graw-Hill Lange; cell function in healthy men. Eur

2012.h. 697-713. J Endocrinol. 2010; 162:729–
14. Suherman SK, Ascobat P. 735. PubMed: 20124412.

Adrenokortikotropin, 18. Yasuda K, Hines E 3rd, Kitabchi
adrenokortikosteroid, analog AE. Hypercortisolism and

sintetik dan antagonisnya. insulin resistance: comparative

Dalam: Gunawan SG, Setiabudy effects of prednisone,
R, Nafrialdi, Instiaty, penyunting. hydrocortisone, and

Farmakologi dan terapi. Edisi dexamethasone on insulin
ke-6. Jakarta: Badan Penerbit binding of human erythrocytes. J

FKUI; 2016. H 507-27. Clin Endocrinol Metab. 1982;
15. Waterloo Wellington Diabetes. 55:910–915. PubMed: 6749880.

(2023). Managing Steroids & 19. van Raalte DH, Ouwens DM,

Hyperglicemua: A Guide for Diamant M. Novel insights into
Health Care Professionals. glucocorticoid-mediated

Ontario: Waterloo Wellington diabetogenic effects: towards
Diabetes. expansion of therapeutic options?

16. Gonzalez-Gonzalez, J.G., Eur J Clin Invest. 2009; 39:81–

Mireles-Zavala, L.G., 93. PubMed: 19200161.
Rodriguez-Gutierrez, R. et 20. McKinnon CM, Docherty K.

al. Hyperglycemia related to Pancreatic duodenal homeobox
high-dose glucocorticoid use in 1, PDX-1, a major regulator of

noncritically ill beta cell identity and function.

patients. Diabetol Metab Syndr 5, Diabetologia. 2001;44:1203-14.
18 (2013). 21. van Raalte DH, Kwa KA, van

Genugten RE, Tushuizen ME,

https://jfklin.rsupfatmawati.co.id/jfklin 45